Supernus Pharmaceuticals (SUPN) Gross Profit Growth (3y) (2016 - 2025)
Supernus Pharmaceuticals (SUPN) Gross Profit Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 0.95% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.31% |
| Sep 30, 2025 | 4.56% |
| Jun 30, 2025 | -0.22% |
| Mar 31, 2025 | -0.13% |
| Dec 31, 2024 | 1.39% |
| Sep 30, 2024 | 6.64% |
| Jun 30, 2024 | 8.95% |
| Mar 31, 2024 | 3.16% |
| Dec 31, 2023 | 4.99% |
| Sep 30, 2023 | 0.13% |
| Mar 31, 2023 | 12.79% |
| Dec 31, 2022 | 14.44% |
| Sep 30, 2022 | 15.89% |
| Jun 30, 2022 | 14.12% |
| Mar 31, 2022 | 18.06% |
| Dec 31, 2021 | 8.33% |
| Sep 30, 2021 | 9.69% |
| Jun 30, 2021 | 6.66% |
| Mar 31, 2021 | 9.99% |
| Dec 31, 2020 | 14.05% |